BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 31201995)

  • 1. Antimicrobial susceptibility testing and antibiotic consumption results from 16 hospitals in Viet Nam: The VINARES project 2012-2013.
    Vu TVD; Do TTN; Rydell U; Nilsson LE; Olson L; Larsson M; Hanberger H; Choisy M; Dao TT; van Doorn HR; Nguyen VK; Nguyen VT; Wertheim HFL;
    J Glob Antimicrob Resist; 2019 Sep; 18():269-278. PubMed ID: 31201995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016-2017.
    Vu TVD; Choisy M; Do TTN; Nguyen VMH; Campbell JI; Le TH; Nguyen VT; Wertheim HFL; Pham NT; Nguyen VK; van Doorn HR;
    Antimicrob Resist Infect Control; 2021 May; 10(1):78. PubMed ID: 33971969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004.
    Lee K; Lim CH; Cho JH; Lee WG; Uh Y; Kim HJ; Yong D; Chong Y;
    Yonsei Med J; 2006 Oct; 47(5):634-45. PubMed ID: 17066507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in antimicrobial resistance of bacterial pathogens in Harare, Zimbabwe, 2012-2017: a secondary dataset analysis.
    Mhondoro M; Ndlovu N; Bangure D; Juru T; Gombe NT; Shambira G; Nsubuga P; Tshimanga M
    BMC Infect Dis; 2019 Aug; 19(1):746. PubMed ID: 31455256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
    Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009.
    Lee K; Kim MN; Kim JS; Hong HL; Kang JO; Shin JH; Park YJ; Yong D; Jeong SH; Chong Y;
    Yonsei Med J; 2011 Sep; 52(5):793-802. PubMed ID: 21786445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
    Mao T; Zhai H; Duan G; Yang H
    Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016.
    Jarlier V; Diaz Högberg L; Heuer OE; Campos J; Eckmanns T; Giske CG; Grundmann H; Johnson AP; Kahlmeter G; Monen J; Pantosti A; Rossolini GM; van de Sande-Bruinsma N; Vatopoulos A; Żabicka D; Žemličková H; Monnet DL; Simonsen GS;
    Euro Surveill; 2019 Aug; 24(33):. PubMed ID: 31431208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance and clonality in Escherichia coli and Klebsiella spp. and relationship with antibiotic consumption in major Lebanese hospitals.
    Daoud Z; Salem-Sokhn E; Dahdouh E; Irani J; Matar GM; Doron S
    J Glob Antimicrob Resist; 2017 Dec; 11():45-51. PubMed ID: 28756026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016.
    Zhang F; Li Y; Lv Y; Zheng B; Xue F
    J Glob Antimicrob Resist; 2019 Jun; 17():276-282. PubMed ID: 30611932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trend in the susceptibility of the most frequent bacterial pathogens isolated at Hospital General La Mancha Centro over 2010-2012 period].
    Asencio MÁ; Huertas M; Carranza R; Franco M; Castellanos J; Barberá JR; Conde Mdel C; Tenías JM
    Rev Esp Quimioter; 2014 Dec; 27(4):261-8. PubMed ID: 25536430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
    Lee K; Park KH; Jeong SH; Lim HS; Shin JH; Yong D; Ha GY; Chong Y; KONSAR group
    Yonsei Med J; 2006 Feb; 47(1):43-54. PubMed ID: 16502484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008.
    Meyer E; Schwab F; Schroeren-Boersch B; Gastmeier P
    Crit Care; 2010; 14(3):R113. PubMed ID: 20546564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.
    Lee K; Lee MA; Lee CH; Lee J; Roh KH; Kim S; Kim JJ; Koh E; Yong D; Chong Y;
    Yonsei Med J; 2010 Nov; 51(6):901-11. PubMed ID: 20879058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance of selected invasive bacteria in a tertiary care center: results of a prospective surveillance study.
    Djuric O; Jovanovic S; Stosovic B; Tosic T; Jovanovic M; Markovic-Denic L
    J Infect Dev Ctries; 2016 Dec; 10(12):1325-1331. PubMed ID: 28036312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in antimicrobial susceptibility patterns in King Fahad Medical City, Riyadh, Saudi Arabia.
    Farah SM; Alshehri MA; Alfawaz TS; Alasmeri FA; Alageel AA; Alshahrani DA
    Saudi Med J; 2019 Mar; 40(3):252-259. PubMed ID: 30834420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16.
    Lagacé-Wiens PRS; Adam HJ; Poutanen S; Baxter MR; Denisuik AJ; Golden AR; Nichol KA; Walkty A; Karlowsky JA; Mulvey MR; Golding G; Hoban DJ; Zhanel GG;
    J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv22-iv31. PubMed ID: 31505648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance and antibiotic consumption in Mexican hospitals.
    Miranda-Novales MG; Flores-Moreno K; López-Vidal Y; Rodríguez-Álvarez M; Solórzano-Santos F; Soto-Hernández JL; Ponce de León-Rosales S;
    Salud Publica Mex; 2020; 62(1):42-49. PubMed ID: 31869560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.